Amalgamated Bank’s CureVac CVAC Stock Holding History

Amalgamated Bank’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-6,263	Closed	-$123K	–	3071
2022 Q1	$123K	Buy	+6,263	New	+$125K	﹤0.01%	2119

Other funds holding CVAC

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

Amalgamated Bank's CVAC Position: Q2 2022 in Review

Amalgamated Bank sold out of CureVac (CVAC) in Q2 2022, closing a stake of 6,263 shares — an estimated $123K sold.

Amalgamated Bank first reported a position in CVAC in Q1 2022 and held it in 1 quarter. The position peaked at $123K in Q1 2022. 88 funds tracked by Wall St. Rank hold CVAC as of Q2 2022.

Amalgamated Bank reported no remaining CureVac position as of Q2 2022 after selling out during the quarter.
Amalgamated Bank sold 6,263 CureVac shares in Q2 2022, an estimated $123K.
Amalgamated Bank first reported a position in CureVac in Q1 2022 and held it in 1 quarter.
Amalgamated Bank's CureVac position peaked at $123K in Q1 2022.
88 funds tracked by Wall St. Rank held CureVac as of Q2 2022.

Based on Amalgamated Bank's 13F filing for Q2 2022, filed 15 Aug 2022.